Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

Allogeneic stem cell transplant-derived T cells have the potential to seek and eliminate sites of residual cancer that escaped primary therapy. Oncolytic myxoma virus (MYXV) exhibits potent anti-cancer efficacy against human cancers like multiple myeloma (MM) and can arm transplant-derived T cells t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Lilly, Cameron L., Villa, Nancy Y., Lemos de Matos, Ana, Ali, Haider M., Dhillon, Jess-Karan S., Hofland, Tom, Rahman, Masmudur M., Chan, Winnie, Bogen, Bjarne, Cogle, Christopher, McFadden, Grant
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363758/
https://ncbi.nlm.nih.gov/pubmed/28345022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2016.12.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados